Person-centred healthcare and public health policy: the role of Multi-Criteria Decision Analysis (MCDA) and Cluster Analysis (CA) in responding to preference heterogeneity by Dowie, Jack & Kaltoft, Mette Kjer
Syddansk Universitet
Person-centred healthcare and public health policy: the role of Multi-Criteria Decision
Analysis (MCDA) and Cluster Analysis (CA) in responding to preference heterogeneity
Dowie, Jack; Kaltoft, Mette Kjer
Publication date:
2014
Document version
Accepted author manuscript
Citation for pulished version (APA):
Dowie, J., & Kaltoft, M. K. (2014). Person-centred healthcare and public health policy: the role of Multi-Criteria
Decision Analysis (MCDA) and Cluster Analysis (CA) in responding to preference heterogeneity. Abstract from
Seminar at the Institute of Health Research, University of Exeter Medical School, Exeter, United Kingdom.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 19. Apr. 2017
Person-centred healthcare and public health policy:
the role of Multi-Criteria Decision Analysis (MCDA) and Cluster 
Analysis (CA) in responding to preference heterogeneity
Jack Dowie
London School of Hygiene and Tropical Medicine
jack.dowie@lshtm.ac.uk
Mette Kjer Kaltoft
University of Southern Denmark
mkaltoft@health.sdu.dk
Institute of Health Research, University of Exeter Medical School 
4 March 2014 

• Mette on clinical decision support for individuals based 
on Multi-criteria Decision Analysis (MCDA)
• Jack on decision/policy support for communities based 
on Cluster Analysis and MCDA
Outline
What’s the matter?
What might be lost?
What matters?

Which is doctor
and which patient?
Final step in ‘bench to bedside’ translation pathway is 
maybe the most difficult
• Decision aids (such as Option Grids) can help, most of 
them providing 
•Structured information
•Possibility of ‘value/preference clarification’
• But leave patient to synthesise these in some sort of  
intuitive ‘making up your mind’ process
• Commitment to ‘evidence-based’ leaves many patient-
important criteria (e.g. side effects) vaguely verbal
Lost in translation?
MCDA-based decision aids are unique in producing 
opinion on best option and rating all options on ratio scale
• patients/persons input preferences in explicit way as
importance weights for all patient-important criteria
• combined with Best Estimates Available Now (BEANs) 
for performance rates of options on these criteria 
• by simple expected value calculation
• prescriptive and eminently defensible
• Provide basis for ‘backward translation’ into research 
priorities by identifying poorly GRADEd cells
Lost in translation?
EVIDENCE ON CRITERION PREFERENCES 
EVIDENCE ON OPTION PERFORMANCE
OPTION SCORES 
PhD research involves delivery of MCDA-based decision support to 
patients with Crohn’s Disease or Ulcerative Colitis preparing for an 
upcoming consultation
• Ratings for different options provided by collaborating clinicians 
depending on disease (2), current state (4) and treatments (9-15)
• 7 Criteria (Mild/Moderate/Severe Disease, Side Effects, Adverse 
Events, Treatment Burden, Relationship Impact) weighted by patient
• 8 item MyDecisionQuality (MDQ) instrument used as primary 
outcome – MDQ is a PROM or PRE(xperience)M depending on 
whether the decision is seen as the outcome of a decision process
• Annalisa implementation of MCDA used (embedded in survey 
program Elicia, via which customisation and personalisation is 
achieved)
Decision Support in Inflammatory Bowel Disease



The Trial
• Active Comparator  – "Fixed" 5 attribute Annalisa decision aid (n = 727)
• Active Intervention  – "Pick Your Own" from 10 attributes (n= 720)
• Participants
Men aged 40-49yrs, 50-59yrs, 60-69yrs  without prostate cancer
• Design
Community survey with GMI panelists within each age block randomly allocated 
to arms
• Primary outcome
Score on 'MyDecisionQuality" continuous scale (0-1)
• Other Outcomes
Stated choice to have a PSA test or not (prior and posterior probability)
Ease of use
1
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• If fully individualised public health care policies are 
impossible
• If treating every person as “average” is not good enough
•What subgroupings represent optimal compromise?
•How are they to be incorporated into public policy? 
•Novel techniques may be needed, including adaptions of 
existing techniques of
•Cost-Effectiveness Analysis (CEA)
•Health Technology Assessment (HTA)
The community issue
SETTING
BASIS OF SUBGROUPING
Individual
Decision
Guideline/
Regulatory
Community/
Public Policy
Biological-clinical
AND/OR 
Socio-demographic 
variables
Well-accepted
and widely 
used in 
practice
Reasonably 
well-accepted 
and some use 
in practice
Well-accepted and used in 
Comparative Effectiveness 
Analysis;
Some, conditional, acceptance 
and use in Cost Effectiveness 
Analysis
Preferences 
AND/OR
Values 
Reasonably 
well-accepted 
and a little 
formal use
Reasonably
well-accepted 
but little 
formal use
Controversial
Widely done informally  ad hoc at 
‘political/institutional’ level;
little enthusiasm for being done 
consistently and transparently
• Individualised Care as Public Policy
• Nease, Owens 1994
• Sculpher 1998  (menorrhagia) 
• Dowie 1998
• Basu, Meltzer 2007 Expected Value of Individualised Care (EVIC)
• Subgrouped Public Policies
• Sculpher, Gafni 2001, 2002 (public or patient preferences)
• Robinson, Parkin 2002
• Brazier, Dixon, Ratcliffe 2009
Sign of times:
• Dirksen 2013 protocol 
Short history of the debate
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• ‘Horizontal’ analysis (in contrast to previous ‘vertical’ analysis)
• Much used in marketing (clusters = ‘segments’)
• A little use in health, mostly on signs and symptoms (e.g. Kent 
et al. on lower back pain)
• Many techniques with different assumptions/value judgments
• Not much liked by classical (bio)statisticians: seen as, at best, 
hypothesis generating preliminary to proper hypothesis testing
• But patterns are patterns and ‘validation’ is problematic 
because no gold standard to regress on
• Especially problematic when we are focusing on preferences
Cluster Analysis
• In Hierarchical Agglomeration methods, individuals are progressively grouped together 
in terms of their similarity, i.e. their mathematical distance from each other in n-
dimensions where n is the number of criteria. Once assigned to a cluster they remain 
permanently in that cluster while the process of assigning unaffiliated individuals 
continues. The Ward method is a special case in that it assigns individuals so as to 
minimise the internal variance of each cluster at that point in the process.
[R package: HCLUST]
• In contrast, in Partitioning methods, the cluster membership of an individual and hence 
the membership of clusters may change throughout the process, though the aim 
remains the same - to end up with a solution that minimises the internal variance 
within clusters relative to a specified centroid (e.g. the medoid, or the mean in the 
kmeans partitioning) and maximises the distance between the cluster centroids. 
[R package: PAMK]
• Unlike partitioning and hierarchical techniques which involve minimising within- and 
maximising between-cluster variance, Latent Class Analysis employs a model-based 
approach in which probabilities of cluster membership are estimated, with individuals 
then assigned to the cluster for which their membership probability is highest.
[R package: MCLUST]
Clustering Techniques






WARD 4  SOLUTION
Cluster 
Number
LOSS OF 
LIFETIME,
NEEDLESS 
BIOPSY
URINARY 
PROBLEMS
BOWEL 
PROBLEMS
SEXUAL 
PROBLEMS Interpretive Label
N %N
A: Mean Criterion Weights 2 0.08 0.07 0.12 0.14 0.59 38 7.3
Very High Sexers
B:  Criterion Ratings from 
trial MCDA
PSA 0.9960 0.7760 0.9760 0.9460 0.5790
No PSA 0.9950 1.0000 0.9820 0.9470 0.6090
C:  Option Scores for 
Ward's Method 4 Cluster 
Solution, plus Score Gap
Score Gap
PSA 2 0.0797 0.0543 0.1171 0.1324 0.3416 0.7252 Very High Sexers
No PSA 0.0796 0.0700 0.1178 0.1326 0.3593 0.7593 0.034
D:  Threshold Changes in 
Lifetime Loss Ratings
SGCW 2 0.4291 Very High Sexers
Threshold 0.5669
%Req 0.43
SGCW = Score Gap  divided  by (Criterion Weight *No PSA Rating on Loss of Lifetime criterion)
Threshold =  No PSA Rating required to eliminate Score Gap
%Req = Percentage change  from PSA Rating to threshold
Cluster LCA4 PAM4 Ward4
Equals 19 25 39
Very High 
Lifers
1 1 1
Moderate 
Lifers
3 6 8
Very High 
Sexers
… 56 43
Moderate 
Biopsers
95 … …
% improvement in PSA Loss of Lifetime Rating required for equipoise in each subgroup 




40-49 years 50-59 years 60-69 years
% 
Change
%N
N=156
% 
Change
%N
N=135
% 
Change
%N
N=97
Moderate 
Lifers
0.1 35 2.7 27 4.1 26
Very High 
Lifers
0.0 25 0.3 24 0.4 14
Equals
0.4 32 3.5 41 21.5 44
Very High 
Sexers
0.2 8 14.4 8 … …
Moderate 
Biopsers
… … … … 45.4 15
k-means cluster analysis found that there were three 
distinct cluster groupings:
• ‘Ready Screeners’ 
• ‘Fearful Avoiders’
• ‘Cautious Screeners’
•Concept and method only…  using data produced for 
individual not community purpose
still to be determined are:
•Structure of policy decision (options, criteria in MCDA)
•Choice of MCDA implementation/software
•Choice of Cluster Analysis technique/s
•Choice of measure of cluster quality
•Trade-off between statistical quality and other criteria
•Whether all persons are equal as persons
Proof of …
•We found an age effect but…
• Is pursuing preferences on basis of associations with 
‘objective’ characteristics such as sex, age, and 
socioeconomic class not ‘reductionist’?
•Reduces preferences to epi-phenomena which can be 
explained (away) by the ‘objective’ characteristics of the 
person – “he or she has these preferences because… “
• ‘Person-centred’ might be seen as requiring ignoring of 
characteristics in relation to preference weightings (as 
opposed to ratings, where ‘personalisation’ is essential)
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